4-83462485-C-G
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong
The NM_139076.3(ABRAXAS1):āc.1214G>Cā(p.Arg405Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000651 in 1,612,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_139076.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152080Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000152 AC: 38AN: 249830Hom.: 0 AF XY: 0.000163 AC XY: 22AN XY: 135100
GnomAD4 exome AF: 0.0000616 AC: 90AN: 1460072Hom.: 0 Cov.: 30 AF XY: 0.0000647 AC XY: 47AN XY: 726286
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152080Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74300
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 29, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 22, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at